We are live on
!
Find out more
ADMA Biologics
ADMA
ADMA
88 hedge funds and large institutions have $137M invested in ADMA Biologics in 2021 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
190% more capital invested
Capital invested by funds: $47.3M → $137M (+$89.8M)
121% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 14
22% more funds holding
Funds holding: 72 → 88 (+16)
17.05% more ownership
Funds ownership: 32.6% → 49.65% (+17%)
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
70% less call options, than puts
Call options by funds: $632K | Put options by funds: $2.12M
Holders
88
Holders Change
+16
Holders Change %
+22.22%
% of All Funds
1.35%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
31
Increased
23
Reduced
21
Closed
14
Calls
$632K
Puts
$2.12M
Net Calls
-$1.49M
Net Calls Change
+$178K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$13M |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$8.31M |
| 3 |
CC
Clearline Capital
New York
|
+$7.37M |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$6.77M |
| 5 |
AIC
AWM Investment Company
New York
|
+$6.02M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$1.75M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$669K |
| 3 |
Millennium Management
New York
|
-$542K |
| 4 |
Morgan Stanley
New York
|
-$432K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$329K |
